Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 513

1.

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 May 30. doi: 10.1038/s41388-019-0835-1. [Epub ahead of print]

PMID:
31147600
2.

Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.

Cecconi D, Brandi J, Manfredi M, Serena M, Carbonare LD, Deiana M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Avanzi F, Antoniazzi F, Marengo E, Tiso N, Mottes M, Zipeto D, Valenti MT.

Sci Rep. 2019 May 29;9(1):8052. doi: 10.1038/s41598-019-44552-1.

3.

Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.

Dalla Grana E, Rigo F, Lanzafame M, Lattuada E, Suardi S, Mottes M, Valenti MT, Dalle Carbonare L.

Front Endocrinol (Lausanne). 2019 May 14;10:302. doi: 10.3389/fendo.2019.00302. eCollection 2019.

4.

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.

Carvalho D, Taylor KR, Olaciregui NG, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM, Jones C.

Commun Biol. 2019 May 9;2:156. doi: 10.1038/s42003-019-0420-8. eCollection 2019.

5.

Electronic Effects Determine the Selectivity of Planar Au-Cu Bimetallic Thin Films for Electrochemical CO2 Reduction.

Liu K, Ma M, Wu L, Valenti M, Cardenas-Morcoso D, Hofmann JP, Bisquert J, Gimenez S, Smith WA.

ACS Appl Mater Interfaces. 2019 May 8;11(18):16546-16555. doi: 10.1021/acsami.9b01553. Epub 2019 Apr 29.

6.

Alteration of myocardial GRK2 produces a global metabolic phenotype.

Woodall BP, Gresham KS, Woodall MA, Valenti MC, Cannavo A, Pfleger J, Chuprun JK, Drosatos K, Koch WJ.

JCI Insight. 2019 Apr 4;5. pii: 123848. doi: 10.1172/jci.insight.123848.

7.

Effects of Oral Anticoagulant Therapy on Gene Expression in Crosstalk between Osteogenic Progenitor Cells and Endothelial Cells.

Dalle Carbonare L, Mottes M, Brunelli A, Deiana M, Cheri S, Suardi S, Valenti MT.

J Clin Med. 2019 Mar 8;8(3). pii: E329. doi: 10.3390/jcm8030329.

8.

Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.

Mercadante S, Adile C, Masedu F, Valenti M, Aielli F.

J Pain Symptom Manage. 2019 May;57(5):966-970. doi: 10.1016/j.jpainsymman.2019.02.014. Epub 2019 Feb 26.

PMID:
30822530
9.

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.

Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E.

Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470. doi: 10.1016/j.euroneuro.2019.02.003. Epub 2019 Feb 12. Review.

PMID:
30770235
10.

Maximizing New Technologies to Treat Depression.

Decker V, Valenti M, Montoya V, Sikorskii A, Given CW, Given BA.

Issues Ment Health Nurs. 2019 Mar;40(3):200-207. doi: 10.1080/01612840.2018.1527422. Epub 2019 Jan 8.

PMID:
30620622
11.

Diketopyrrolopyrrole Bis-Phosphonate Conjugate: A New Fluorescent Probe for In Vitro Bone Imaging.

Chiminazzo A, Borsato G, Favero A, Fabbro C, McKenna CE, Dalle Carbonare LG, Valenti MT, Fabris F, Scarso A.

Chemistry. 2019 Mar 7;25(14):3617-3626. doi: 10.1002/chem.201805436. Epub 2019 Feb 12.

PMID:
30600841
12.

Vitamin D Daily versus Monthly Administration: Bone Turnover and Adipose Tissue Influences.

Dalle Carbonare L, Valenti MT, Del Forno F, Piacentini G, Pietrobelli A.

Nutrients. 2018 Dec 6;10(12). pii: E1934. doi: 10.3390/nu10121934.

13.

New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.

Deiana M, Dalle Carbonare L, Serena M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Manfredi M, Marengo E, Brandi J, Cecconi D, Mori A, Mina MM, Antoniazzi F, Mottes M, Tiso N, Malerba G, Zipeto D, Valenti MT.

Cells. 2018 Nov 20;7(11). pii: E220. doi: 10.3390/cells7110220.

14.

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Mar;38(10):1717-1733. doi: 10.1038/s41388-018-0554-z. Epub 2018 Oct 23. Erratum in: Oncogene. 2019 May 30;:.

PMID:
30353166
15.

Preliminary analysis of effects of the 2006 Turin Winter Olympic Games on air quality.

Senese A, Valenti M, Senese V.

PLoS One. 2018 Oct 18;13(10):e0205975. doi: 10.1371/journal.pone.0205975. eCollection 2018.

16.

Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4 H-1,2,4-triazol-3-yl)phenyl)-6-methyl- N8-neopentylpyrido[3,4- d]pyrimidine-2,8-diamine (BOS172722).

Woodward HL, Innocenti P, Cheung KJ, Hayes A, Roberts J, Henley AT, Faisal A, Mak GW, Box G, Westwood IM, Cronin N, Carter M, Valenti M, De Haven Brandon A, O'Fee L, Saville H, Schmitt J, Burke R, Broccatelli F, van Montfort RLM, Raynaud FI, Eccles SA, Linardopoulos S, Blagg J, Hoelder S.

J Med Chem. 2018 Sep 27;61(18):8226-8240. doi: 10.1021/acs.jmedchem.8b00690. Epub 2018 Sep 10.

17.

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Banerji U, Sain N, Sharp SY, Valenti M, Asad Y, Ruddle R, Raynaud F, Walton M, Eccles SA, Judson I, Jackman AL, Workman P.

Cancer Chemother Pharmacol. 2018 Nov;82(5):911-912. doi: 10.1007/s00280-018-3674-9.

PMID:
30173339
18.

Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later.

Mercadante S, Marinangeli F, Masedu F, Valenti M, Russo D, Ursini L, Massici A, Aielli F.

J Pain Symptom Manage. 2018 Dec;56(6):902-907. doi: 10.1016/j.jpainsymman.2018.08.018. Epub 2018 Aug 31.

PMID:
30172864
19.

Cine 4DCT imaging artifacts: Quantification and correlations with scanning parameters and target kinetics.

Valenti M, Campanelli A, Parisotto M, Maggi S.

Phys Med. 2018 Aug;52:133-142. doi: 10.1016/j.ejmp.2018.07.006. Epub 2018 Jul 30.

PMID:
30139602
20.

Ectopic expression of the osteogenic master gene RUNX2 in melanoma.

Valenti MT, Dalle Carbonare L, Mottes M.

World J Stem Cells. 2018 Jul 26;10(7):78-81. doi: 10.4252/wjsc.v10.i7.78.

21.

Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder.

Bonnín CM, Martínez-Arán A, Reinares M, Valentí M, Solé B, Jiménez E, Montejo L, Vieta E, Rosa AR.

J Affect Disord. 2018 Nov;240:57-62. doi: 10.1016/j.jad.2018.07.045. Epub 2018 Jul 17.

PMID:
30053684
22.

Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.

Mercadante S, Adile C, Lanzetta G, Mystakidou K, Maltoni M, Guilherme Soares L, De Santis S, Ferrera P, Valenti M, Rosati M, Rossi R, Cortegiani A, Masedu F, Marinangeli F, Aielli F.

Oncologist. 2019 Feb;24(2):239-246. doi: 10.1634/theoncologist.2017-0668. Epub 2018 May 16.

PMID:
29769382
23.

Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study.

Goikolea JM, Dima D, Landín-Romero R, Torres I, DelVecchio G, Valentí M, Amann BL, Bonnín CM, McKenna PJ, Pomarol-Clotet E, Frangou S, Vieta E.

Schizophr Bull. 2019 Mar 7;45(2):464-473. doi: 10.1093/schbul/sby047.

PMID:
29672741
24.

Diet: the keystone of autism spectrum disorder?

Peretti S, Mariano M, Mazzocchetti C, Mazza M, Pino MC, Verrotti Di Pianella A, Valenti M.

Nutr Neurosci. 2018 Apr 19:1-15. doi: 10.1080/1028415X.2018.1464819. [Epub ahead of print]

PMID:
29669486
25.

An integrated approach identifies new oncotargets in melanoma.

Cecconi D, Carbonare LD, Mori A, Cheri S, Deiana M, Brandi J, Degaetano V, Masiero V, Innamorati G, Mottes M, Malerba G, Valenti MT.

Oncotarget. 2017 Dec 15;9(14):11489-11502. doi: 10.18632/oncotarget.23727. eCollection 2018 Feb 20.

26.

The curious case of Gαs gain-of-function in neoplasia.

Innamorati G, Wilkie TM, Kantheti HS, Valenti MT, Dalle Carbonare L, Giacomello L, Parenti M, Melisi D, Bassi C.

BMC Cancer. 2018 Mar 15;18(1):293. doi: 10.1186/s12885-018-4133-z.

27.

Can disc diffusion susceptibility tests assess the antimicrobial activity of engineered nanoparticles?

Kourmouli A, Valenti M, van Rijn E, Beaumont HJE, Kalantzi OI, Schmidt-Ott A, Biskos G.

J Nanopart Res. 2018;20(3):62. doi: 10.1007/s11051-018-4152-3. Epub 2018 Mar 2.

28.

Predictors of Underrepresented Nursing Students' School Satisfaction, Success, and Future Education Intent.

Williams LB, Bourgault AB, Valenti M, Howie M, Mathur S.

J Nurs Educ. 2018 Mar 1;57(3):142-149. doi: 10.3928/01484834-20180221-03.

PMID:
29505071
29.

The role of sleep in aesthetic perception and empathy: A mediation analysis.

Peretti S, Tempesta D, Socci V, Pino MC, Mazza M, Valenti M, De Gennaro L, Di Dio C, Marchetti A, Ferrara M.

J Sleep Res. 2019 Jun;28(3):e12664. doi: 10.1111/jsr.12664. Epub 2018 Feb 6.

PMID:
29405533
30.

Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review).

Valenti MT, Dalle Carbonare L, Mottes M.

Int J Mol Med. 2018 May;41(5):2441-2449. doi: 10.3892/ijmm.2018.3452. Epub 2018 Feb 1. Review.

PMID:
29393379
31.

Hot Carrier Generation and Extraction of Plasmonic Alloy Nanoparticles.

Valenti M, Venugopal A, Tordera D, Jonsson MP, Biskos G, Schmidt-Ott A, Smith WA.

ACS Photonics. 2017 May 17;4(5):1146-1152. doi: 10.1021/acsphotonics.6b01048. Epub 2017 Mar 6.

32.

Runx2 overexpression compromises bone quality in acromegalic patients.

Valenti MT, Mottes M, Cheri S, Deiana M, Micheletti V, Cosaro E, Davì MV, Francia G, Dalle Carbonare L.

Endocr Relat Cancer. 2018 Mar;25(3):269-277. doi: 10.1530/ERC-17-0523. Epub 2018 Jan 2.

PMID:
29295822
33.

Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder.

Bonnín CM, Yatham LN, Michalak EE, Martínez-Arán A, Dhanoa T, Torres I, Santos-Pascual C, Valls E, Carvalho AF, Sánchez-Moreno J, Valentí M, Grande I, Hidalgo-Mazzei D, Vieta E, Reinares M.

J Affect Disord. 2018 Mar 1;228:153-159. doi: 10.1016/j.jad.2017.12.006. Epub 2017 Dec 6.

PMID:
29248821
34.

Clodronate as a Therapeutic Strategy against Osteoarthritis.

Valenti MT, Mottes M, Biotti A, Perduca M, Pisani A, Bovi M, Deiana M, Cheri S, Dalle Carbonare L.

Int J Mol Sci. 2017 Dec 13;18(12). pii: E2696. doi: 10.3390/ijms18122696.

35.

Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Davì MV.

Pituitary. 2018 Feb;21(1):56-64. doi: 10.1007/s11102-017-0847-1.

PMID:
29214508
36.

[Bone biopsy in the Chronic Kidney Disease (CKD)].

Dalle Carbonare L, Valenti MT.

G Ital Nefrol. 2017 Dec 5;34(Nov-Dec). pii: 2017-vol6. Review. Italian.

PMID:
29207224
37.

The use of choline in association with the Bangerter filters for the treatment of amblyopia.

Sabetti L, Masedu F, Tresca C, Bianchi F, Valenti M.

Int J Ophthalmol. 2017 Nov 18;10(11):1777-1778. doi: 10.18240/ijo.2017.11.22. eCollection 2017.

38.

Effects of nutraceuticals on sexual satisfaction and lower urinary tract symptoms in a cohort of young-old men.

Perri A, Ilacqua A, Valenti M, Aversa A.

Phytother Res. 2018 Feb;32(2):284-289. doi: 10.1002/ptr.5971. Epub 2017 Nov 23.

PMID:
29168235
39.

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?

Guadagni S, Fiorentini G, Clementi M, Palumbo G, Palumbo P, Chiominto A, Baldoni S, Masedu F, Valenti M, Tommaso AD, Fabi B, Aliberti C, Sarti D, Guadagni V, Pellegrini C.

Int J Mol Sci. 2017 Nov 9;18(11). pii: E2382. doi: 10.3390/ijms18112382.

40.

Can half-marathon affect overall health? The yin-yang of sport.

Dalle Carbonare L, Manfredi M, Caviglia G, Conte E, Robotti E, Marengo E, Cheri S, Zamboni F, Gabbiani D, Deiana M, Cecconi D, Schena F, Mottes M, Valenti MT.

J Proteomics. 2018 Jan 6;170:80-87. doi: 10.1016/j.jprot.2017.09.004. Epub 2017 Sep 6.

PMID:
28887210
41.

Efficacy and safety in frameless robot-assisted stereo-electroencephalography (SEEG) for drug-resistant epilepsy.

Ollivier I, Behr C, Cebula H, Timofeev A, Benmekhbi M, Valenti MP, Staack AM, Scholly J, Kehrli P, Hirsch E, Proust F.

Neurochirurgie. 2017 Sep;63(4):286-290. doi: 10.1016/j.neuchi.2017.03.002. Epub 2017 Sep 4.

PMID:
28882607
42.

Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial function.

Joseph LC, Kokkinaki D, Valenti MC, Kim GJ, Barca E, Tomar D, Hoffman NE, Subramanyam P, Colecraft HM, Hirano M, Ratner AJ, Madesh M, Drosatos K, Morrow JP.

JCI Insight. 2017 Sep 7;2(17). pii: 94248. doi: 10.1172/jci.insight.94248. eCollection 2017 Sep 7.

43.

Construct validity of the Functional Assessment of Verbal Reasoning and Executive Strategies (FAVRES).

Higginson CI, Thompson T, Benjamin AE, Rosales AC, Zane KL, Valenti M, Ibrahim K, Rock MA, Chaffee TA.

Brain Inj. 2017;31(13-14):1807-1812. doi: 10.1080/02699052.2017.1347278. Epub 2017 Aug 22.

PMID:
28829667
44.

Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability.

Guadagni S, Palumbo G, Fiorentini G, Clementi M, Marsili L, Giordano AV, Masedu F, Valenti M.

BMC Res Notes. 2017 Aug 15;10(1):411. doi: 10.1186/s13104-017-2738-y.

45.

GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers.

Innamorati G, Valenti MT, Giacomello L, Dalle Carbonare L, Bassi C.

Trends Cancer. 2016 Jun;2(6):282-285. doi: 10.1016/j.trecan.2016.05.005. Epub 2016 Jun 1.

PMID:
28741526
46.

Monolithic lithium disilicate complete single crowns with feather-edge preparation design in the posterior region: A multicentric retrospective study up to 12 years.

Schmitz JH, Cortellini D, Granata S, Valenti M.

Quintessence Int. 2017 Jul 20:601-608. doi: 10.3290/j.qi.a38678. [Epub ahead of print]

PMID:
28740971
47.

Evaluation of Patient Satisfaction in a State Reference Center of Bipolar Disorder.

Garrido JM, Sánchez-Moreno J, Vázquez M, Hidalgo D, Valentí M, Goikolea JM, Benabarre A, Ylla A, Grande I, Vieta E, Trilla A.

J Behav Health Serv Res. 2019 Apr;46(2):319-329. doi: 10.1007/s11414-017-9561-z. No abstract available.

PMID:
28707257
48.

Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis.

Guadagni S, Fiorentini G, Clementi M, Palumbo G, Chiominto A, Cappelli S, Masedu F, Valenti M.

J Surg Res. 2017 Jul;215:114-124. doi: 10.1016/j.jss.2017.03.066. Epub 2017 Apr 7.

PMID:
28688635
49.

Vitamin D: Daily vs. Monthly Use in Children and Elderly-What Is Going On?

Dalle Carbonare L, Valenti MT, Del Forno F, Caneva E, Pietrobelli A.

Nutrients. 2017 Jun 24;9(7). pii: E652. doi: 10.3390/nu9070652.

50.

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Ang JE, Pal A, Asad YJ, Henley AT, Valenti M, Box G, de Haven Brandon A, Revell VL, Skene DJ, Venturi M, Rueger R, Meresse V, Eccles SA, de Bono JS, Kaye SB, Workman P, Banerji U, Raynaud FI.

Mol Cancer Ther. 2017 Oct;16(10):2315-2323. doi: 10.1158/1535-7163.MCT-16-0881. Epub 2017 Jun 21.

Supplemental Content

Loading ...
Support Center